346 related articles for article (PubMed ID: 33837463)
21. From real world data to real world evidence to improve outcomes in neuro-ophthalmology.
Colman BD; Zhu Z; Qi Z; van der Walt A
Eye (Lond); 2024 Jun; ():. PubMed ID: 38844583
[TBL] [Abstract][Full Text] [Related]
22. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
[TBL] [Abstract][Full Text] [Related]
23. Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements.
Sievers H; Joos A; Hiligsmann M
Int J Technol Assess Health Care; 2021 Feb; 37():e40. PubMed ID: 33622423
[TBL] [Abstract][Full Text] [Related]
24. Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making.
Solà-Morales O; Sigurðardóttir K; Akehurst R; Murphy LA; Mestre-Ferrandiz J; Cunningham D; de Pouvourville G
Value Health; 2023 Apr; 26(4S):32-42. PubMed ID: 36870678
[TBL] [Abstract][Full Text] [Related]
25. Real-world evidence to support regulatory decision making: New or expanded medical product indications.
Franklin JM; Liaw KL; Iyasu S; Critchlow CW; Dreyer NA
Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):685-693. PubMed ID: 33675248
[TBL] [Abstract][Full Text] [Related]
26. Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement.
Snyder JM; Pawloski JA; Poisson LM
Curr Oncol Rep; 2020 Apr; 22(5):45. PubMed ID: 32297007
[TBL] [Abstract][Full Text] [Related]
27. The Current Landscape and Emerging Applications for Real-World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making.
Baumfeld Andre E; Carrington N; Siami FS; Hiatt JC; McWilliams C; Hiller C; Surinach A; Zamorano A; Pashos CL; Schulz WL
Clin Pharmacol Ther; 2022 Dec; 112(6):1172-1182. PubMed ID: 35213741
[TBL] [Abstract][Full Text] [Related]
28. A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases.
Vaghela S; Tanni KA; Banerjee G; Sikirica V
Orphanet J Rare Dis; 2024 Mar; 19(1):117. PubMed ID: 38475874
[TBL] [Abstract][Full Text] [Related]
29. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.
Facile R; Muhlbradt EE; Gong M; Li Q; Popat V; Pétavy F; Cornet R; Ruan Y; Koide D; Saito TI; Hume S; Rockhold F; Bao W; Dubman S; Jauregui Wurst B
JMIR Med Inform; 2022 Jan; 10(1):e30363. PubMed ID: 35084343
[TBL] [Abstract][Full Text] [Related]
30. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes.
Anderson P; Higgins V; Courcy J; Doslikova K; Davis VA; Karavali M; Piercy J
Curr Med Res Opin; 2023 Dec; 39(12):1707-1715. PubMed ID: 37933204
[TBL] [Abstract][Full Text] [Related]
31. Big data and real-world data-based medicine in the management of hypertension.
Okada M
Hypertens Res; 2021 Feb; 44(2):147-153. PubMed ID: 33250517
[TBL] [Abstract][Full Text] [Related]
32. What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward.
Kc S; Lin LW; Bayani DBS; Zemlyanska Y; Adler A; Ahn J; Chan K; Choiphel D; Genuino-Marfori AJ; Kearney B; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Akmal Shafie A; Sui B; Suwantika A; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Teerawattananon Y; Wee HL
Int J Health Policy Manag; 2023; 12():6858. PubMed ID: 37579427
[TBL] [Abstract][Full Text] [Related]
33. Contribution of Real-World Evidence in European Medicines Agency's Regulatory Decision Making.
Bakker E; Plueschke K; Jonker CJ; Kurz X; Starokozhko V; Mol PGM
Clin Pharmacol Ther; 2023 Jan; 113(1):135-151. PubMed ID: 36254408
[TBL] [Abstract][Full Text] [Related]
34. Integration of real-world evidence from different data sources in health technology assessment.
Graili P; Guertin JR; Chan KKW; Tadrous M
J Pharm Pharm Sci; 2023; 26():11460. PubMed ID: 37529633
[TBL] [Abstract][Full Text] [Related]
35. Reality check: Real-world evidence to support therapeutic development in hematologic malignancies.
Derman BA; Belli AJ; Battiwalla M; Hamadani M; Kansagra A; Lazarus HM; Wang CK
Blood Rev; 2022 May; 53():100913. PubMed ID: 35272867
[TBL] [Abstract][Full Text] [Related]
36. The use of real-world data/evidence in regulatory submissions.
Song F; Zang C; Ma X; Hu S; Sun Q; Chow SC; Sun H
Contemp Clin Trials; 2021 Oct; 109():106521. PubMed ID: 34339865
[TBL] [Abstract][Full Text] [Related]
37. Conducting real-world evidence studies in India.
Bhatt A
Perspect Clin Res; 2019; 10(2):51-56. PubMed ID: 31008069
[TBL] [Abstract][Full Text] [Related]
38. Data Science Methods for Real-World Evidence Generation in Real-World Data.
Liu F
Annu Rev Biomed Data Sci; 2024 May; ():. PubMed ID: 38748863
[TBL] [Abstract][Full Text] [Related]
39. Current status of real-world big data research in the cardiovascular field in Japan.
Tonegawa-Kuji R; Kanaoka K; Iwanaga Y
J Cardiol; 2023 Mar; 81(3):307-315. PubMed ID: 36126909
[TBL] [Abstract][Full Text] [Related]
40. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
F1000Res; 2018; 7():111. PubMed ID: 30026923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]